Peng Zhang

6PUBLICATIONS

25CO-AUTHORS

Cardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)Medical biochemistry - inorganic elements and compoundsMedical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 19, 2026

SBK2-Driven NDUFV1 Phosphorylation and Translocation Limits Cardiac Hypertrophy.

|Apr 21, 2026

Deubiquitinase USP43 exacerbates myocardial ischemia-reperfusion injury by stabilizing ASK1 and activating the JNK/P38 MAPK pathway.

|Jan 06, 2026

Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.

Ke-Qiong Deng, Zhendong Xu, Qiongxin Wang

|Dec 08, 2025

E3 Ubiquitin Ligase TRIM21 Exacerbates Pathological Cardiac Hypertrophy Through ASK1 K63-Linked Polyubiquitination.

Hongjie Shi, Jing Xie, Sha Hu

|Sep 01, 2025

ApoE Mimetic Peptide-MsrA Fusion Protein Restores HDL Function and Ameliorates Atherosclerosis via Circulatory Redox Remodeling in SR-BI Deficient Mice.

Yu Liu, Jun-Xing Pu, Xin Yang

|Apr 19, 2022

The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.

Jiayi Liu, Wei Li, Ke-Qiong Deng

Pageof 1

Frequent Collaborators

Zhi-Gang She

Ke-Qiong Deng

Tian Tian

Yan-Xiao Ji

Shaoze Chen

Jingjing Cai

Hongliang Li

Yu Liu

Jun-Xing Pu

Hong Yu

Frequent Collaborators

Zhi-Gang She

Ke-Qiong Deng

Tian Tian

Yan-Xiao Ji